Showing Form 4 filings for MPLT
Pre-configured institutional-grade criteria for instant high-conviction screening
Multiple insiders buying stock within the last 30 days
Direct open-market purchases by Chief Executive Officers
Financial chiefs and top corporate officers accumulating shares
Institutional-scale insider purchases of $1,000,000 or greater
Insiders increasing their overall equity ownership by over 20%
High-value executive divestments by CEOs and CFOs over $1M
Maplight Therapeutics, Inc.
Price
$7.84
Shares
12,248
Ownership
168,678
Value/Share
Kreitzer Anatol
Chief Discovery Officer
Industry
$8.08
10,167
142,315
Gillis Jonathan
CAO, Interim CFO
11,513
198,597
Lillie James Woodruff
Chief Scientific Officer
9,020
128,024
Hanson Kristopher
GC
15,355
296,906
Foff Erin Pennock
Chief Medical Officer
73,691
1,297,099
Kroeger Christopher A.
CEO